Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Peg-Epoetin Beta, Atc B03xa03 for the Period February 1St, 2023 - January 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Lipegfilgrastim, Atc L03aa14 for the Period February 1St, 2023 - January 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Ranolazine, Atc C01eb18 for the Period February 1St, 2023 - January 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Ciclospiron, Atc L04ad01 for the Period February 1St, 2023 - January 31St, 2025

Open House Biologics Rebate Contracts 2022-22 - Peginterferon Beta-1A

Open House Original Rebate Agreements 2022-17 - Tiotropium Bromide (Spiriva(R) Respimat, Atc: R03bb04)

Open House Contracts for Multiple Active Ingredients/Active Ingredient Combinations

Medicines Containing the Active Substance Mesalazine (Atc: A07ec02)

Medicines Containing the Active Ingredient Epinephrine (Atc: C01ca24)

Drugs Containing the Active Ingredient Permethrin (Atc: P03ac04)